{"DataElement":{"publicId":"4993815","version":"1","preferredName":"Eligibility Criteria MGMT Methylation Status Available Indicator","preferredDefinition":"Indicator of whether or not the patient has tumor MGMT methylation status available.","longName":"4993783v1.0:3506068v1.0","context":"ABTC","contextVersion":"1","DataElementConcept":{"publicId":"4993783","version":"1","preferredName":"Clinical Trial Eligibility Criteria MGMT Methylation Assay Experimental Result Status Available","preferredDefinition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._An assay to determine the pattern of methylation in the promoter of the MGMT gene. Aberrant methylation of the MGMT promoter is associated with squamous cell carcinoma._The outcome of an experiment or set of experiments, including observations and primary, processed, and analyzed data._A condition or state at a particular time._The quality of being obtainable or accessible and ready for use or service.","longName":"2767728v1.0:4993781v1.0","context":"ABTC","contextVersion":"1","ObjectClass":{"publicId":"2767728","version":"1","preferredName":"Clinical Trial Eligibility Criteria","preferredDefinition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"529EA070-682D-67A0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-22","endDate":null,"createdBy":"UMLLOADER_WCI","dateCreated":"2008-07-22","modifiedBy":"ONEDATA","dateModified":"2008-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4993781","version":"1","preferredName":"MGMT Methylation Assay Experimental Result Status Availability","preferredDefinition":"An assay to determine the pattern of methylation in the promoter of the MGMT gene. Aberrant methylation of the MGMT promoter is associated with squamous cell carcinoma.:The outcome of an experiment or set of experiments, including observations and primary, processed, and analyzed data.:A condition or state at a particular time.:The quality of being obtainable or accessible and ready for use or service.","longName":"C79101:C76125:C25688:C25429","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MGMT Methylation Assay","conceptCode":"C79101","definition":"An assay to determine the pattern of methylation in the promoter of the MGMT gene. Aberrant methylation of the MGMT promoter is associated with squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Experimental Result","conceptCode":"C76125","definition":"The outcome of an experiment or set of experiments, including observations and primary, processed, and analyzed data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Availability","conceptCode":"C25429","definition":"The quality of being obtainable or accessible and ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EA12EA1-74B9-D10B-E050-BB89AD435A71","latestVersionIndicator":"Yes","beginDate":"2015-08-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-31","modifiedBy":"ONEDATA","dateModified":"2015-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EA12EA1-74CA-D10B-E050-BB89AD435A71","latestVersionIndicator":"Yes","beginDate":"2015-08-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for ABTC-1402 study in Rave per request by R.Marasigan. mc 8/31/2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4280691","version":"1","longName":"CRF CDEs","context":"ABTC","ClassificationSchemeItems":[{"publicId":"4280724","version":"1","longName":"Eligibility Checklist","context":"ABTC"}]}],"AlternateNames":[{"name":"ABTC","type":"USED_BY","context":"ABTC"}],"ReferenceDocuments":[{"name":"Does the patient have availab","type":"Preferred Question Text","description":"Does the patient have available tumor MGMT methylation status from routinely used methods for MGMT methylation testing?","url":null,"context":"ABTC"},{"name":"Acceptable Routine MGMT Methylation Test Methods","type":"NOTE","description":"Results of routinely used methods for MGMT methylation testing (e.g. MSPCR or quantitative PCR) are acceptable.","url":null,"context":"ABTC"},{"name":"ABTC 1501 Question Text","type":"Alternate Question Text","description":"Does the patient have readily available tumor MGMT methylation status from routinely used methods for MGMT methylation testing?","url":null,"context":"ABTC"},{"name":"Alt Question Text 1051","type":"Alternate Question Text","description":"Does the patient have available tumor MGMT methylation status? Results of routinely used methods for MGMT methylation testing (e.g. MSPCR or quantitative PCR) are acceptable.","url":null,"context":"ABTC"},{"name":"ABTC 1801 Text 1","type":"Alternate Question Text","description":"Does the patient have available MGMT methylation status?","url":null,"context":"ABTC"},{"name":"ABTC 1801 Text 2","type":"Alternate Question Text","description":"Does the patient have available MGMT methylation testing?","url":null,"context":"ABTC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EA1AC3D-49FD-2996-E050-BB89AD433AFF","latestVersionIndicator":"Yes","beginDate":"2015-08-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-31","modifiedBy":"TSESU","dateModified":"2020-08-21","changeDescription":"Created for 1402 study in Rave per request by R.Marasigan. mc 8/31/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}